Analysis of Solvency Ratios
Quarterly Data
Solvency ratios also known as long-term debt ratios measure a company ability to meet long-term obligations.
Solvency Ratios (Summary)
McKesson Corp., solvency ratios (quarterly data)
Based on: 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-K (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-K (reporting date: 2015-03-31), 10-Q (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-K (reporting date: 2014-03-31), 10-Q (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-K (reporting date: 2013-03-31), 10-Q (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-K (reporting date: 2012-03-31), 10-Q (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-K (reporting date: 2011-03-31), 10-Q (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30).
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to equity ratio | A solvency ratio calculated as total debt divided by total shareholders’ equity. | McKesson Corp. debt to equity ratio improved from Q4 2016 to Q1 2017 and from Q1 2017 to Q2 2017. |
| Debt to capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. | McKesson Corp. debt to capital ratio improved from Q4 2016 to Q1 2017 and from Q1 2017 to Q2 2017. |
| Debt to assets ratio | A solvency ratio calculated as total debt divided by total assets. | McKesson Corp. debt to assets ratio improved from Q4 2016 to Q1 2017 and from Q1 2017 to Q2 2017. |
| Financial leverage ratio | A solvency ratio calculated as total assets divided by total shareholders’ equity. | McKesson Corp. financial leverage ratio decreased from Q4 2016 to Q1 2017 and from Q1 2017 to Q2 2017. |
| Solvency ratio | Description | The company |
|---|---|---|
| Interest coverage ratio | A solvency ratio calculated as EBIT divided by interest payments. | McKesson Corp. interest coverage ratio improved from Q4 2016 to Q1 2017 but then deteriorated significantly from Q1 2017 to Q2 2017. |
Debt to Equity
McKesson Corp., debt to equity calculation (quarterly data)
| Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Short-term borrowings | —) | —) | 7) | 7) | 142) | 144) | 135) | 407) | 525) | 507) | 346) | —) | —) | —) | —) | —) | —) | —) | 400) | —) | —) | —) | —) | —) | —) | —) | ||||||||
| Current portion of long-term debt | 2,166) | 2,168) | 1,612) | 996) | 1,110) | 1,510) | 1,529) | 1,006) | 427) | 25) | 1,424) | 353) | 353) | 352) | 352) | 506) | 508) | 508) | 508) | 409) | 414) | 414) | 417) | 1,757) | —) | —) | ||||||||
| Long-term debt, excluding current portion | 5,941) | 5,942) | 6,535) | 7,715) | 8,136) | 8,142) | 8,180) | 8,981) | 9,620) | 10,141) | 8,949) | 4,521) | 4,521) | 4,522) | 4,521) | 3,973) | 3,073) | 3,072) | 3,072) | 3,578) | 3,578) | 3,575) | 3,587) | 2,305) | 2,279) | 2,278) | ||||||||
| Total debt | 8,107) | 8,110) | 8,154) | 8,718) | 9,388) | 9,796) | 9,844) | 10,394) | 10,572) | 10,673) | 10,719) | 4,874) | 4,874) | 4,874) | 4,873) | 4,479) | 3,581) | 3,580) | 3,980) | 3,987) | 3,992) | 3,989) | 4,004) | 4,062) | 2,279) | 2,278) | ||||||||
| Total McKesson Corporation stockholders’ equity | 9,449) | 9,249) | 8,924) | 8,876) | 8,788) | 8,853) | 8,001) | 9,084) | 8,931) | 8,979) | 8,522) | 8,027) | 7,989) | 7,408) | 7,070) | 7,649) | 7,715) | 7,203) | 6,831) | 7,456) | 7,116) | 6,917) | 7,220) | 7,080) | 6,815) | 6,879) | ||||||||
| Solvency Ratio | ||||||||||||||||||||||||||||||||||
| Debt to equity1 | 0.86 | 0.88 | 0.91 | 0.98 | 1.07 | 1.11 | 1.23 | 1.14 | 1.18 | 1.19 | 1.26 | 0.61 | 0.61 | 0.66 | 0.69 | 0.59 | 0.46 | 0.50 | 0.58 | 0.53 | 0.56 | 0.58 | 0.55 | 0.57 | 0.33 | 0.33 | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Debt to Equity, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-K (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-K (reporting date: 2015-03-31), 10-Q (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-K (reporting date: 2014-03-31), 10-Q (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-K (reporting date: 2013-03-31), 10-Q (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-K (reporting date: 2012-03-31), 10-Q (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-K (reporting date: 2011-03-31), 10-Q (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30).
1 Q2 2017 Calculation
Debt to equity = Total debt ÷ Total McKesson Corporation stockholders’ equity
= 8,107 ÷ 9,449 = 0.86
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to equity ratio | A solvency ratio calculated as total debt divided by total shareholders’ equity. | McKesson Corp. debt to equity ratio improved from Q4 2016 to Q1 2017 and from Q1 2017 to Q2 2017. |
Debt to Capital
McKesson Corp., debt to capital calculation (quarterly data)
| Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Short-term borrowings | —) | —) | 7) | 7) | 142) | 144) | 135) | 407) | 525) | 507) | 346) | —) | —) | —) | —) | —) | —) | —) | 400) | —) | —) | —) | —) | —) | —) | —) | ||||||||
| Current portion of long-term debt | 2,166) | 2,168) | 1,612) | 996) | 1,110) | 1,510) | 1,529) | 1,006) | 427) | 25) | 1,424) | 353) | 353) | 352) | 352) | 506) | 508) | 508) | 508) | 409) | 414) | 414) | 417) | 1,757) | —) | —) | ||||||||
| Long-term debt, excluding current portion | 5,941) | 5,942) | 6,535) | 7,715) | 8,136) | 8,142) | 8,180) | 8,981) | 9,620) | 10,141) | 8,949) | 4,521) | 4,521) | 4,522) | 4,521) | 3,973) | 3,073) | 3,072) | 3,072) | 3,578) | 3,578) | 3,575) | 3,587) | 2,305) | 2,279) | 2,278) | ||||||||
| Total debt | 8,107) | 8,110) | 8,154) | 8,718) | 9,388) | 9,796) | 9,844) | 10,394) | 10,572) | 10,673) | 10,719) | 4,874) | 4,874) | 4,874) | 4,873) | 4,479) | 3,581) | 3,580) | 3,980) | 3,987) | 3,992) | 3,989) | 4,004) | 4,062) | 2,279) | 2,278) | ||||||||
| Total McKesson Corporation stockholders’ equity | 9,449) | 9,249) | 8,924) | 8,876) | 8,788) | 8,853) | 8,001) | 9,084) | 8,931) | 8,979) | 8,522) | 8,027) | 7,989) | 7,408) | 7,070) | 7,649) | 7,715) | 7,203) | 6,831) | 7,456) | 7,116) | 6,917) | 7,220) | 7,080) | 6,815) | 6,879) | ||||||||
| Total capital | 17,556) | 17,359) | 17,078) | 17,594) | 18,176) | 18,649) | 17,845) | 19,478) | 19,503) | 19,652) | 19,241) | 12,901) | 12,863) | 12,282) | 11,943) | 12,128) | 11,296) | 10,783) | 10,811) | 11,443) | 11,108) | 10,906) | 11,224) | 11,142) | 9,094) | 9,157) | ||||||||
| Solvency Ratio | ||||||||||||||||||||||||||||||||||
| Debt to capital1 | 0.46 | 0.47 | 0.48 | 0.50 | 0.52 | 0.53 | 0.55 | 0.53 | 0.54 | 0.54 | 0.56 | 0.38 | 0.38 | 0.40 | 0.41 | 0.37 | 0.32 | 0.33 | 0.37 | 0.35 | 0.36 | 0.37 | 0.36 | 0.36 | 0.25 | 0.25 | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Debt to Capital, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-K (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-K (reporting date: 2015-03-31), 10-Q (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-K (reporting date: 2014-03-31), 10-Q (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-K (reporting date: 2013-03-31), 10-Q (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-K (reporting date: 2012-03-31), 10-Q (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-K (reporting date: 2011-03-31), 10-Q (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30).
1 Q2 2017 Calculation
Debt to capital = Total debt ÷ Total capital
= 8,107 ÷ 17,556 = 0.46
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. | McKesson Corp. debt to capital ratio improved from Q4 2016 to Q1 2017 and from Q1 2017 to Q2 2017. |
Debt to Assets
McKesson Corp., debt to assets calculation (quarterly data)
| Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Short-term borrowings | —) | —) | 7) | 7) | 142) | 144) | 135) | 407) | 525) | 507) | 346) | —) | —) | —) | —) | —) | —) | —) | 400) | —) | —) | —) | —) | —) | —) | —) | ||||||||
| Current portion of long-term debt | 2,166) | 2,168) | 1,612) | 996) | 1,110) | 1,510) | 1,529) | 1,006) | 427) | 25) | 1,424) | 353) | 353) | 352) | 352) | 506) | 508) | 508) | 508) | 409) | 414) | 414) | 417) | 1,757) | —) | —) | ||||||||
| Long-term debt, excluding current portion | 5,941) | 5,942) | 6,535) | 7,715) | 8,136) | 8,142) | 8,180) | 8,981) | 9,620) | 10,141) | 8,949) | 4,521) | 4,521) | 4,522) | 4,521) | 3,973) | 3,073) | 3,072) | 3,072) | 3,578) | 3,578) | 3,575) | 3,587) | 2,305) | 2,279) | 2,278) | ||||||||
| Total debt | 8,107) | 8,110) | 8,154) | 8,718) | 9,388) | 9,796) | 9,844) | 10,394) | 10,572) | 10,673) | 10,719) | 4,874) | 4,874) | 4,874) | 4,873) | 4,479) | 3,581) | 3,580) | 3,980) | 3,987) | 3,992) | 3,989) | 4,004) | 4,062) | 2,279) | 2,278) | ||||||||
| Total assets | 58,315) | 57,904) | 56,563) | 55,087) | 55,819) | 55,925) | 53,870) | 55,110) | 52,232) | 53,006) | 51,759) | 36,479) | 35,947) | 35,491) | 34,786) | 33,433) | 32,968) | 31,748) | 33,093) | 33,157) | 31,907) | 31,017) | 30,886) | 30,396) | 26,792) | 27,399) | ||||||||
| Solvency Ratio | ||||||||||||||||||||||||||||||||||
| Debt to assets1 | 0.14 | 0.14 | 0.14 | 0.16 | 0.17 | 0.18 | 0.18 | 0.19 | 0.20 | 0.20 | 0.21 | 0.13 | 0.14 | 0.14 | 0.14 | 0.13 | 0.11 | 0.11 | 0.12 | 0.12 | 0.13 | 0.13 | 0.13 | 0.13 | 0.09 | 0.08 | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Debt to Assets, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-K (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-K (reporting date: 2015-03-31), 10-Q (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-K (reporting date: 2014-03-31), 10-Q (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-K (reporting date: 2013-03-31), 10-Q (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-K (reporting date: 2012-03-31), 10-Q (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-K (reporting date: 2011-03-31), 10-Q (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30).
1 Q2 2017 Calculation
Debt to assets = Total debt ÷ Total assets
= 8,107 ÷ 58,315 = 0.14
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to assets ratio | A solvency ratio calculated as total debt divided by total assets. | McKesson Corp. debt to assets ratio improved from Q4 2016 to Q1 2017 and from Q1 2017 to Q2 2017. |
Financial Leverage
McKesson Corp., financial leverage calculation (quarterly data)
| Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Total assets | 58,315) | 57,904) | 56,563) | 55,087) | 55,819) | 55,925) | 53,870) | 55,110) | 52,232) | 53,006) | 51,759) | 36,479) | 35,947) | 35,491) | 34,786) | 33,433) | 32,968) | 31,748) | 33,093) | 33,157) | 31,907) | 31,017) | 30,886) | 30,396) | 26,792) | 27,399) | ||||||||
| Total McKesson Corporation stockholders’ equity | 9,449) | 9,249) | 8,924) | 8,876) | 8,788) | 8,853) | 8,001) | 9,084) | 8,931) | 8,979) | 8,522) | 8,027) | 7,989) | 7,408) | 7,070) | 7,649) | 7,715) | 7,203) | 6,831) | 7,456) | 7,116) | 6,917) | 7,220) | 7,080) | 6,815) | 6,879) | ||||||||
| Solvency Ratio | ||||||||||||||||||||||||||||||||||
| Financial leverage1 | 6.17 | 6.26 | 6.34 | 6.21 | 6.35 | 6.32 | 6.73 | 6.07 | 5.85 | 5.90 | 6.07 | 4.54 | 4.50 | 4.79 | 4.92 | 4.37 | 4.27 | 4.41 | 4.84 | 4.45 | 4.48 | 4.48 | 4.28 | 4.29 | 3.93 | 3.98 | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Financial Leverage, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-K (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-K (reporting date: 2015-03-31), 10-Q (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-K (reporting date: 2014-03-31), 10-Q (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-K (reporting date: 2013-03-31), 10-Q (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-K (reporting date: 2012-03-31), 10-Q (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-K (reporting date: 2011-03-31), 10-Q (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30).
1 Q2 2017 Calculation
Financial leverage = Total assets ÷ Total McKesson Corporation stockholders’ equity
= 58,315 ÷ 9,449 = 6.17
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Financial leverage ratio | A solvency ratio calculated as total assets divided by total shareholders’ equity. | McKesson Corp. financial leverage ratio decreased from Q4 2016 to Q1 2017 and from Q1 2017 to Q2 2017. |
Interest Coverage
McKesson Corp., interest coverage calculation (quarterly data)
| Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Net income attributable to McKesson Corporation | 307) | 542) | 431) | 634) | 617) | 576) | 132) | 472) | 469) | 403) | 371) | 64) | 404) | 424) | 259) | 298) | 401) | 380) | 521) | 300) | 296) | 286) | 422) | 155) | 327) | 298) | ||||||||
| Add: Net income attributable to noncontrolling interest | 17) | 18) | 13) | 13) | 13) | 13) | 12) | 39) | 8) | 8) | (5) | —) | —) | —) | —) | —) | —) | —) | —) | —) | —) | —) | —) | —) | —) | —) | ||||||||
| Less: Income (loss) from discontinued operations, net of tax | (1) | (113) | (21) | 5) | (6) | (10) | (267) | (10) | (14) | (8) | 4) | (92) | (12) | 4) | —) | —) | —) | —) | —) | —) | —) | —) | —) | —) | 72) | —) | ||||||||
| Add: Income tax expense | 200) | 239) | 204) | 204) | 244) | 256) | 209) | 198) | 223) | 185) | 103) | 252) | 213) | 174) | 127) | 138) | 165) | 151) | 136) | 126) | 124) | 130) | 136) | 106) | 121) | 142) | ||||||||
| Add: Interest expense | 78) | 79) | 86) | 87) | 91) | 89) | 90) | 93) | 95) | 96) | 116) | 69) | 59) | 59) | 70) | 59) | 55) | 56) | 59) | 64) | 64) | 64) | 82) | 53) | 44) | 43) | ||||||||
| Earnings before interest and tax (EBIT) | 603) | 991) | 755) | 933) | 971) | 944) | 710) | 812) | 809) | 700) | 581) | 477) | 688) | 653) | 456) | 495) | 621) | 587) | 716) | 490) | 484) | 480) | 640) | 314) | 420) | 483) | ||||||||
| Solvency Ratio | ||||||||||||||||||||||||||||||||||
| Interest coverage1 | 9.95 | 10.64 | 10.21 | 9.97 | 9.47 | 8.92 | 8.10 | 7.26 | 6.83 | 7.19 | 7.92 | 8.85 | 9.28 | 9.16 | 9.00 | 10.56 | 10.32 | 9.37 | 8.65 | 7.64 | 7.29 | 7.63 | 8.36 | — | — | — | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Interest Coverage, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-K (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-K (reporting date: 2015-03-31), 10-Q (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-K (reporting date: 2014-03-31), 10-Q (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-K (reporting date: 2013-03-31), 10-Q (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-K (reporting date: 2012-03-31), 10-Q (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-K (reporting date: 2011-03-31), 10-Q (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30).
1 Q2 2017 Calculation
Interest coverage
= (EBITQ2 2017
+ EBITQ1 2017
+ EBITQ4 2016
+ EBITQ3 2016)
÷ (Interest expenseQ2 2017
+ Interest expenseQ1 2017
+ Interest expenseQ4 2016
+ Interest expenseQ3 2016)
= (603 + 991 + 755 + 933)
÷ (78 + 79 + 86 + 87)
= 9.95
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Interest coverage ratio | A solvency ratio calculated as EBIT divided by interest payments. | McKesson Corp. interest coverage ratio improved from Q4 2016 to Q1 2017 but then deteriorated significantly from Q1 2017 to Q2 2017. |